Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells

• Hiroyuki Sako,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Kazumasa Fukuda,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Yoshiro Saikawa ,

  * E-mail: saiky@z8.keio.jp

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Rieko Nakamura,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Tsunehiro Takahashi,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Norihito Wada,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Hirohumi Kawakubo,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Hiroya Takeuchi,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Tai Ohmori,

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯
• Yuko Kitagawa

  Affiliation Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan

  ⨯